ESPE Yearbook of Paediatric Endocrinology

To read the full abstract: J Clin Endocrinol Metab. 2018 Aug 1; 103(8):2785GH deficiency (GHD) is common among children treated for cancer, especially among childhood cancer survivors (CCS) with tumors/surgery in the hypothalamic-pituitary (HP) region, CCS exposed to HP radiation or CCS exposed to cranial (CIR), craniospinal (CSI), or total body irradiation (TBI). However, most of existi...

To read the full abstract: Horm Res Paediatr. 2018; 90(5): 314This single-centre, retrospective study analyzes the screening role of low IGF-1 levels in the diagnosis of growth hormone deficiency (GHD) in a cohort of 158 childhood cancer survivors (CCS) and in a selected sub-cohort of 117 CCS who received radiation for tumours not directly involving the hypothalamic-pituitary (HP) area (...

To read the full abstract: J Clin Endocrinol Metab. 2018 Aug 1; 103(8): 2794This systematic review and meta-analysis was conducted by a US Endocrine Society Task Force in order to inform new guidelines on the management of childhood cancer survivors (CCS). The aim of this review was to evaluate the effects of GH therapy on final height, risk of diabetes mellitus, lipid abnormalities, met...